Medical Properties Trust (NYSE:MPW) Coverage Initiated at Berenberg Bank

Equities research analysts at Berenberg Bank began coverage on shares of Medical Properties Trust (NYSE:MPW) in a research note issued to investors on Thursday, The Fly reports. The firm set a “buy” rating on the real estate investment trust’s stock.

Several other research analysts also recently issued reports on MPW. Zacks Investment Research downgraded Medical Properties Trust from a “hold” rating to a “sell” rating in a research report on Wednesday, July 17th. Stifel Nicolaus set a $21.00 price objective on Medical Properties Trust and gave the stock a “buy” rating in a research report on Monday, August 12th. Deutsche Bank upgraded Medical Properties Trust from a “hold” rating to a “buy” rating in a research report on Monday, July 29th. ValuEngine downgraded Medical Properties Trust from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Finally, JPMorgan Chase & Co. set a $21.00 price objective on Medical Properties Trust and gave the stock a “buy” rating in a research report on Wednesday, September 4th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $19.35.

Shares of Medical Properties Trust stock opened at $18.73 on Thursday. The company has a debt-to-equity ratio of 0.99, a current ratio of 8.00 and a quick ratio of 8.00. Medical Properties Trust has a 1 year low of $13.98 and a 1 year high of $19.26. The company has a market capitalization of $8.30 billion, a P/E ratio of 13.67, a P/E/G ratio of 3.68 and a beta of 0.56. The business has a 50 day moving average price of $18.24 and a 200 day moving average price of $18.15.

Medical Properties Trust (NYSE:MPW) last issued its quarterly earnings data on Thursday, August 1st. The real estate investment trust reported $0.31 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.31. Medical Properties Trust had a return on equity of 6.84% and a net margin of 129.20%. The firm had revenue of $192.55 million during the quarter, compared to the consensus estimate of $186.11 million. During the same period in the previous year, the firm posted $0.36 EPS. The company’s quarterly revenue was down 4.6% compared to the same quarter last year. As a group, research analysts expect that Medical Properties Trust will post 1.3 EPS for the current fiscal year.

In other Medical Properties Trust news, insider R Steven Hamner sold 70,000 shares of Medical Properties Trust stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $17.77, for a total value of $1,243,900.00. Following the completion of the sale, the insider now directly owns 1,312,957 shares of the company’s stock, valued at approximately $23,331,245.89. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Emmett E. Mclean sold 100,000 shares of Medical Properties Trust stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $18.37, for a total transaction of $1,837,000.00. Following the completion of the sale, the insider now directly owns 1,066,337 shares of the company’s stock, valued at $19,588,610.69. The disclosure for this sale can be found here. 1.18% of the stock is currently owned by insiders.

A number of hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its stake in shares of Medical Properties Trust by 4.4% during the 2nd quarter. Vanguard Group Inc. now owns 59,568,283 shares of the real estate investment trust’s stock valued at $1,038,870,000 after buying an additional 2,531,875 shares during the period. BlackRock Inc. grew its stake in shares of Medical Properties Trust by 1.6% during the 2nd quarter. BlackRock Inc. now owns 45,070,249 shares of the real estate investment trust’s stock valued at $786,026,000 after buying an additional 702,061 shares during the period. Bank of New York Mellon Corp grew its stake in shares of Medical Properties Trust by 6.3% during the 2nd quarter. Bank of New York Mellon Corp now owns 11,407,543 shares of the real estate investment trust’s stock valued at $198,948,000 after buying an additional 676,813 shares during the period. LSV Asset Management grew its stake in shares of Medical Properties Trust by 1.9% during the 1st quarter. LSV Asset Management now owns 10,444,707 shares of the real estate investment trust’s stock valued at $193,331,000 after buying an additional 195,400 shares during the period. Finally, Bank of America Corp DE grew its stake in shares of Medical Properties Trust by 33.1% during the 2nd quarter. Bank of America Corp DE now owns 5,779,755 shares of the real estate investment trust’s stock valued at $100,799,000 after buying an additional 1,438,268 shares during the period. 71.37% of the stock is owned by hedge funds and other institutional investors.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Further Reading: How Do Front-End Loads Impact an Investment?

The Fly

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply